TITAN PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Titan Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q4 2023.
  • Titan Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $47K.
  • Titan Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $1.01M, a 6.97% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $1.01M, a 6.97% increase from 2022.
  • Titan Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $947K, a 37.1% decline from 2021.
  • Titan Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $1.51M, a 21400% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.01M $47K +$66K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $947K $411K -$112K -21.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.06M $265K +$48K +22.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 $1.01M $290K +$64K +28.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $947K -$19K -$174K -112% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.12M $523K -$132K -20.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.25M $217K -$230K -51.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.48M $226K -$22K -8.87% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.51M $155K +$152K +5067% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.35M $655K +$646K +7178% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $707K $447K +$368K +466% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $339K $248K +$332K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $7K $3K +$45K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$38K $9K -$119K -93% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $81K $79K -$271K -77.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $352K -$84K -$220K -162% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $572K -$42K -$377K -113% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $949K $128K -$260K -67% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.21M $350K -$52K -12.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.26M $136K -$296K -68.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.56M $335K -$145K -30.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $1.7M $388K -$16K -3.96% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.72M $402K +$20K +5.24% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.7M $432K +$11K +2.61% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $1.69M $480K +$224K +87.5% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 $1.46M $404K +$202K +100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.26M $382K +$133K +53.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.13M $421K +$89K +26.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $1.04M $256K -$111K -30.2% Oct 1, 2016 Dec 31, 2016 10-K/A 2019-04-02
Q3 2016 $1.15M $202K +$110K +120% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $1.04M $249K +$173K +228% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $867K $332K -$159K -32.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.03M $367K +$281K +327% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 $745K $92K +$21K +29.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $724K $76K +$16K +26.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $708K $491K +$165K +50.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $543K $86K +$64K +291% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $479K $71K +$50K +238% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $429K $60K -$70K -53.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $499K $326K -$179K -35.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $678K $22K -$326K -93.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $1M $21K -$344K -94.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $1.35M $130K -$186K -58.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $1.53M $505K -$1.05M -67.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $2.58M $348K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-31
Q3 2012 $365K +$126K +52.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $316K -$114K -26.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $1.55M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $239K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $430K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.